CME Group stock: Morgan Stanley raises target for CME Group stock from USD 330 to USD 337

Published on 10/21/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley set a USD 337 target on October 9, 2026. CME Group stock costs EUR 260.75 on October 21, 2026, minus 0.44 percent versus the Xetra close.

Analyst target and results

Morgan Stanley raised its CME Group target to USD 337 from USD 330 on October 9, 2026.
Third-quarter 2026 revenue reached USD 1.74 billion, up 13.00 percent from the prior-year quarter.
CME Group stock costs EUR 260.75 at Lang & Schwarz on October 21, 2026 at 3:35 p.m. CEST, minus 0.44 percent versus the Xetra close of October 20, 2026.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte, Goldstift und Futures-Dokumenten — CME Group Inc. Flatlay mit Aktienzertifikat und ISIN-Karte, US12572Q1058 inmitten von Finanzinstrumenten arrangiert, Illustration mit AI erstellt.

CME Group Inc. (ISIN US12572Q1058) is trading at EUR 260.75 at Lang & Schwarz on October 21, 2026 at 3:35 p.m. CEST, minus 0.44 percent versus the Xetra close of October 20, 2026 at EUR 261.90. Morgan Stanley raised its price target for CME Group from USD 330 to USD 337 on October 9, 2026, according to Benzinga. The new target is 15.08 percent above the USD 292.83 Nasdaq price reported at 9:44 a.m. ET on October 21, 2026.

Third-quarter revenue reaches USD 1.74 billion

CME Group reported third-quarter 2026 revenue of USD 1.74 billion, up 13.00 percent from USD 1.54 billion in the third quarter of 2025. Adjusted diluted earnings per share came to USD 3.02, above the USD 2.99 FactSet consensus, while GAAP diluted earnings per share were USD 2.89, according to Morningstar on October 21, 2026.

Stock stays inside its yearly range

The USD 292.83 Nasdaq price stood between CME Group's USD 218.31 52-week low and USD 329.16 52-week high on October 21, 2026. The shares were 11.04 percent below the high and 34.14 percent above the low. CME Group's market capitalization was USD 105.3 billion, with a trailing P/E ratio of 24.07.

Valuation and peer context

CME Group's third-quarter operating profit was USD 1.14 billion, producing a 66.00 percent operating margin. The company operates futures and options marketplaces across interest rates, equity indexes, foreign exchange, agricultural commodities, energy and metals.

Comparison with peers

CME Group Inc.: P/E 24.07, market capitalization USD 105.3 billion. Intercontinental Exchange (NYSE, USD): minus 0.38 percent, P/E 22.29, market capitalization USD 88.7 billion. Nasdaq (Nasdaq, USD): plus 0.35 percent, P/E 27.71, market capitalization USD 53.2 billion.

What the target means for CME Group

The Morgan Stanley target places the stock 15.08 percent above the Nasdaq price used for comparison. The valuation sits below Nasdaq's P/E of 27.71 but above Intercontinental Exchange's 22.29, while CME Group's third-quarter revenue growth reached 13.00 percent.

At Lang & Schwarz, CME Group stock was trading at EUR 260.75 on October 21, 2026 at 3:35 p.m. CEST, minus 0.44 percent versus the Xetra close of October 20, 2026 at EUR 261.90. The further course of trading is shown by the continuously updated real-time quote of CME Group stock.